loading page

Oroxylin A promotes cancer cell-to-macrophage communication and improves immunotherapy in hepatocellular carcinoma model
  • +7
  • Peiwen Wang,
  • Xuefeng Zhang,
  • Zhi Feng,
  • Yufang Tang,
  • Xiaolei Han,
  • Tianxiao Mao,
  • Sichan Li,
  • Zhiyu Li,
  • Qinglong Guo,
  • Xiaobo Zhang
Peiwen Wang
China Pharmaceutical University
Author Profile
Xuefeng Zhang
China Pharmaceutical University
Author Profile
Zhi Feng
China Pharmaceutical University
Author Profile
Yufang Tang
China Pharmaceutical University
Author Profile
Xiaolei Han
China Pharmaceutical University
Author Profile
Tianxiao Mao
China Pharmaceutical University
Author Profile
Sichan Li
China Pharmaceutical University
Author Profile
Zhiyu Li
China Pharmaceutical University
Author Profile
Qinglong Guo
China Pharmaceutical University
Author Profile
Xiaobo Zhang
China Pharmaceutical University

Corresponding Author:[email protected]

Author Profile

Abstract

Emerging evidence suggest that oroxylin A, a natural flavonoid compound, induces apoptosis in HCC through multiple mechanisms. However, whether oroxylin A-induced apoptosis could exhibit modulatory effect on tumor microenvironment remains unclear. Here we investigate the effect of oroxylin A on communication between cancer cells and macrophages in vitro and mouse model. The data shows oroxylin A elicits apoptosis-related extracellular vesicles through caspase 3-mediated ROCK1 activation in HCC cells, which are able to regulate M1-like polarization of macrophage. Moreover, oroxylin A downregulates the population of M2-like macrophage and increase in T cells infiltration in tumor microenvironment, accompanied with suppression of HCC development and enhancement of immune checkpoint inhibitor treatment. Mechanistically, glycolysis proteins enriched in oroxylin A-elicited extracellular vesicles from HCC cells is transferred to macrophages where it contributes to ROS-dependent NLRP3 inflammasome activation, therefore promoting anti-tumor phenotype of macrophage. Taken together, this study highlights oroxylin A promotes metabolic shifts between tumor cells and macrophages, facilitating to inhibit tumor development and improve immunotherapy response in HCC model.